From professional translators, enterprises, web pages and freely available translation repositories.
kreatiniinikliirens
creatinine clearance
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kreatiniinikliirens (clcr) (ml/min)
creatinine clearance (clcr) (ml/min)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kreatiniinikliirens pregabaliini kogu ööpäevane
creatinine
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
kreatiniinikliirens [ml/ min] 45... 60 30... 44 15... 29
45 – 60 30 – 44 15 – 29
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
raske neerukahjustuse korral (kreatiniinikliirens <30 ml/min).
severe renal impairment (creatinine clearance <30 ml/min).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
peata manustamine ja jätka neerutalitluse monitoorimist (kreatiniin vereseerumis ja kreatiniinikliirens)
stop dose and continue monitoring renal function (serum creatinine or creatinine clearance)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
patsientide kohta, kelle kreatiniinikliirens on alla 30 ml/min, farmakokineetilised andmed puuduvad.
no pharmacokinetic data are available in patients with creatinine clearance of less than 30 ml/min.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
puudub asenapiini kasutamise kogemus raske neerukahjustusega patsientidel, kelle kreatiniinikliirens on alla 15 ml/min.
there is no experience with asenapine in patients with severe renal impairment who have a creatinine clearance less than 15 ml/min.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kerge neerukahjustusega patsientidel (kreatiniinikliirens 50...80 ml/min) ei ole vaja annust kohandada.
no dose adjustment is needed for patients with mild renal impairment (clcr 50 to
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hulgimüeloomi või soliidtuumori luumetastaasidega patsientide ravi alustamisel tuleb määrata seerumi kreatiniinisisaldus ja kreatiniinikliirens (clcr).
when initiating treatment with zometa in patients with multiple myeloma or metastatic bone lesions from solid tumours, serum creatinine and creatinine clearance (clcr) should be determined.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hulgimüeloomi või soliidtuumori luumetastaasidega patsientide ravi alustamisel zoledroonhappega tuleb määrata seerumi kreatiniinisisaldus ja kreatiniinikliirens (clcr).
when initiating treatment with zoledronic acid in patients with multiple myeloma or metastatic bone lesions from solid tumours, serum creatinine and creatinine clearance (clcr) should be determined.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
rasburikaasi farmakokineetikat täiskasvanutel (≥18 aasta vanused) ei mõjutanud vanus, sugu, maksaensüümide lähteväärtused ja kreatiniinikliirens.
in adults (≥ the age of 18 years), age, gender, baseline liver enzymes and creatinine clearance did not impact the pharmacokinetics of rasburicase.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kui kreatiniinikliirens väheneb alla 50 ml/min, tuleb dutrebis vahetada üksikkomponentide (lamivudiini ja raltegraviiri) vastu.
if creatinine clearance decreases to <50 ml/min, dutrebis should be switched to a regimen of the individual components (lamivudine and raltegravir).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
multiipelmüeloomi või soliidtuumori luumetastaasidega patsientide ravi alustamisel zoledronic acid teva’ga tuleb määrata seerumi kreatiniinisisaldus ja kreatiniinikliirens (clcr).
when initiating treatment with zoledronic acid teva in patients with multiple myeloma or metastatic bone lesions from solid tumours, serum creatinine and creatinine clearance (clcr) should be determined.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
piisavate andmete puudumise tõttu tuleb kinereti kasutamisel mõõduka neerukahjustusega patsientidel (kreatiniinikliirens 30...50 ml/min) olla ettevaatlik.
in the absence of adequate data, kineret should be used with caution in patients with moderate renal impairment (clcr 30 to 50 ml/minute).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
adrovance’i ei soovitata kasutada neerukahjustuse korral, kui kreatiniinikliirens on alla 35 ml/min (vt lõik 4.2).
adrovance is not recommended for patients with renal impairment where creatinine clearance is less than 35 ml/min (see section 4.2).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kinereti ei tohi kasutada raske neerukahjustusega patsientidel (kreatiniinikliirens < 30 ml/min) (vt lõik 4.2).
kineret must not be used in patients with severe renal impairment (clcr < 30 ml/minute) (see section 4.2).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
raske neerupuudulikkusega (kreatiniinikliirens < 30 ml/min) patsientide kohta on andmed vähesed, mistõttu nendel patsientidel peab rosiglitasooni kasutama ettevaatusega.
limited data are available in patients with severe renal insufficiency (creatinine clearance < 30 ml/min) and therefore rosiglitazone should be used with caution in these patients.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
Warning: Contains invisible HTML formatting
kineret’ i ei tohi kasutada raske neerukahjustusega patsientidel (kreatiniinikliirens < 30 ml/ min) (vt lõik 4. 2).
kineret should not be used in patients with severe renal impairment (clcr < 30 ml/ minute) (see section 4.2).
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
Warning: Contains invisible HTML formatting
neerufunktsiooni häirega patsiendid avandamet’ i ei tohi kasutada neerupuudulikkuse või neerufunktsiooni häirega patsientidel (seerumi kreatiniinisisaldus > 135 μmol/ l meestel ja > 110 μmol/ l naistel ja/ või kreatiniinikliirens < 70 ml/ min) (vt lõigud 4. 3 ja 4. 4).
patients with renal impairment avandamet should not be used in patients with renal failure or renal dysfunction e. g. serum creatinine levels > 135 μ mol/ l in males and > 110 μ mol/ l in females and/ or creatinine clearance < 70 ml/ min (see sections 4.3 and 4.4).
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
Warning: Contains invisible HTML formatting